New insights into the pathogenesis of pulmonary inflammation in preterm infants

Biology of the Neonate

Volumn 79, Issue 3-4, 2001, Pages 205-209

  Speer, Christian P ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Cytokines; Inflammation; Oxidative damage; Preterm infants

Indexed keywords

CYTOKINE; LIPID; OXYGEN RADICAL; PROTEINASE;

AIRWAY; ANGIOGENESIS; CHRONIC LUNG DISEASE; CONFERENCE PAPER; CYTOKINE PRODUCTION; INFLAMMATION; INFLAMMATORY CELL; INTRAUTERINE INFECTION; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG INJURY; LUNG INTERSTITIUM; OXIDATIVE STRESS; PATHOGENESIS; PREMATURITY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN DEGRADATION;

BRONCHOPULMONARY DYSPLASIA; CHORIOAMNIONITIS; CHRONIC DISEASE; CYTOKINES; ENDOPEPTIDASES; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFECTION; LUNG DISEASES; MACROPHAGES; NEUTROPHILS; OXYGEN; PREGNANCY; RESPIRATION, ARTIFICIAL;

EID: 0035079108     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047092     Document Type: Conference Paper

References (89)

1. Van Marter LJ, Allred EN, Pagano M: Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? Pediatrics 2000;105:1194-1201.
2. Bancalari E, Gonzalez A: Clinical course and lung function abnormalities during development of neonatal chronic lung disease; in Bland RD, Coalson JJ (eds): Chronic Lung Disease in Early Infancy. New York, Marcel Dekker, 2000, pp 41-64.
3. Groneck P, Speer CP: Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 1995;73:F1-F3.
4. Kotecha S: Cytokines in chronic lung disease of prematurity. Eur J Pediatr 1996;155(suppl 2): S14-S17.
5. Özdemir A, Brown MA, Morgan WJ: Markers and mediators of inflammation in neonatal lung disease. Pediatr Pulmonol 1997;23:292-306.
6. Pierce MR, Bancalari E: The role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Pediatr Pulmonol 1995;19:371-378.
7. Zimmermann JJ: Bronchoalveolar inflammatory pathophysiology of bronchopulmonary dysplasia. Clin Perinatol 1995;22:429-456.
8. Speer CP, Groneck P: Oxygen radicals, cytokines, adhesion molecules and lung injury in neonates. Semin Neonatol 1998;3:219-228.
9. 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. J Clin Invest 1983;72:656-666.
10. Arnon S, Grigg J, Silverman M: Pulmonary inflammatory cells in ventilated preterm infants: Effect of surfactant treatment. Arch Dis Child 1993;69:44-48.
11. Groneck P, Götze-Speer B, Oppermann M, Eiffert H, Speer CP: Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: A sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm infants. Pediatrics 1994;93:712-718.
12. Kotecha S, Chan B, Azam N, Silverman M, Shaw RJ: Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage of premature infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1995;72:F90-F96.
13. Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD: Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis 1984;130:817-821.
14. Jackson JC, MacKenzie AP, Chi EY, Standaert TA, Truog WE, Hodson WA: Mechanisms for reduced total lung capacity at birth and during hyaline membrane disease in premature newborn monkeys. Am Rev Respir Dis 1990;142:413-419.
15. Clement A, Chadelat K, Sardet A, Grimfeld A, Tournier G: Alveolar macrophage status in bronchopulmonary dysplasia. Pediatr Res 1988;23: 470-473.
16. Rindfleisch MS, Hasday JD, Taciak V, Broderick K, Viscardi RM: Potential role of interleukin-1 in the development of bronchopulmonary dysplasia. J Interferon Cytokine Res 1996;16:365-373.
17. Murch SH, Costeloe K, Klein NJ, Rees H, McIntosh N, Keeling JW, MacDonald TT: Mucosal tumor necrosis factor-α production and extensive disruption of sulfated glycosaminoglycans begin within hours of birth in neonatal respiratory distress syndrome. Pediatr Res 1996;40:484-489.
18. Speer CP, Johnston RB: Neutrophil function in newborn infants; in Polin RA, Fox WW (eds): Fetal and Neonatal Physiology. Philadelphia, Saunders, 1998, vol 2, pp 1954-1960.
19. Grigg J, Riedler J, Robertson CF, Boyle W, Uren S: Alveolar macrophage immaturity in infants and young children. Fur Respir J 1999;14:1198-1205.
20. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, Fanaroff AA, Lemons JA, Donovan EF, Oh W, Stevenson DK, Ehrenkranz RA, Papile LA, Verter J, Wright L: Early-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996;129:72-80.
21. Groneck P, Oppermann M, Speer CP: Levels of complement anaphylatoxin C5a in pulmonary effluent fluid of infants at risk for chronic lung disease and effects of dexamethasone treatment. Pediatr Res 1993;34:586-590.
22. Kunkel SL, Standiford T, Kasahara K, Strieter RM: Interleukin-8 (IL-8): The major neutrophil chemotactic factor in the lung. Exp Lung Res 1991; 17:17-23.
23. Stenmark KR, Eyzaguirre M, Westcott JY, Henson PM, Murphy RC: Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia. Am Rev Respir Dis 1987;136:770-772.
24. Jones CA, Cayabyab RG, Kwong KY, Stotts C, Wong B, Hamdan H, Minoo P, DeLemos RA: Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: A possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996;39:966-975.
25. Jónsson B, Tullus K, Brauner A, Lu Y, Noack G: Early increase of TNFα and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed 1997;77:F198-F201.
26. Speer CP: Inflammatory mechanisms in neonatal chronic lung disease. Eur J Pediatr 1999;158(suppl 1):S18-S22.
27. Little S, Dean T, Bevin S, Hall M, Ashton M, Church M, Warner J, Shute J: Role of elevated plasma soluble ICAM-1 and bronchial lavage fluid IL-8 levels as markers of chronic lung disease in premature infants. Thorax 1995;50:1073-1079.
28. Munshi UK, Niu JO, Siddiq MM, Parton LA: Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol 1997;24:331-336.
29. Takasaki J, Ogawa Y: Interleukin 8 and granulocyte elastase in the tracheobronchial aspirate of infants without respiratory distress syndrome or intrauterine infection and development of chronic lung disease. Acta Paediatr Jpn 1997;39:437-441.
30. Inwald DP, Costeloe K, Murch SH: High concentrations of GRO-α and MCP-1 in bronchoalveolar fluid of infants with respiratory distress syndrome after surfactant. Arch Dis Child Fetal Neonatal Ed 1998;78:F234-F235.
31. Kotecha S, Silverman M, Shaw RJ, Klein M: Soluble L-selectin concentration in bronchoalveolar fluid obtained from infants who develop chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 1998;78:F143-F147.
32. Brus F, van Oeveren W, Okken A, Bambang Oetomo S: Activation of the plasma clotting, fibrinolytic, and kinin-kallikrein system in preterm infants with severe idiopathic respiratory distress syndrome. Pediatr Res 1994;36:647-653.
33. Brus F, van Oeveren W, Okken A, Bambang Oetomo S: Activation of circulating polymorphonuclear leukocytes in preterm infants with severe idiopathic respiratory distress syndrome. Pediatr Res 1996; 39:456-463.
34. Saugstad OD, BuoL, Johansen HT, Roise O, Aasen AO: Activation of the plasma kallikrein-kinin system in respiratory distress syndrome. Pediatr Res 1992;32:431-435.
35. Groneck P, Schmale J, Soditt V, Stützer J, Götze-Speer B, Speer CP: Bronchoalveolar inflammation following airway infection in preterm infants with chronic lung disease. Pediatr Pulmonol, in press.
36. Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw RJ: Increase in interleukin (IL)-1α and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res 1996;40:250-256.
37. Kotecha S: Pathophysiology of chronic lung disease or prematurity. Biol Neonate 2000;78:236-237.
38. Jobe AH, Ikegami M: Mechanisms initiating lung injury in the preterm. Early Hum Dev 1998;53:81-94.
39. Muscedere JG, Mullen JBM, Gan K, Slutsky AS: Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med 1994;149:1327-1334.
40. Dreyfuss D, Saumon G: Ventilator-induced lung injury: Lessons from experimental studies. Am J Respir Crit Care Med 1998;157:294-323.
41. Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS: Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997;99:944-952.
42. Vlahakis NE, Schroeder MA, Limper AH, Hubmayr RD: Stretch induces cytokine release by alveolar epithelial cells in vitro. Am J Physiol 1999; 277:L167-L173.
43. Yoder BA, Siler-Khodr T, Winter VT, Coalson JJ: High frequency oscillatory ventilation - effects on lung function, mechanics, and airway cytokines in the immature baboon model for neonatal chronic lung disease. Am J Respir Crit Care Med 2000;162: 1867-1876.
44. Thome U, Götze-Speer B, Speer CP, Pohlandt F: Comparison of pulmonary inflammatory mediators in preterm infants treated with intermittent positive pressure ventilation or high frequency oscillatory ventilation. Pediatr Res 1998;44:330-337.
45. Lyon A: Chronic lung disease of prematurity. The role of intra-uterine infection. Eur J Pediatr 2000; 159:798-802.
46. Hallman M: Cytokines, pulmonary surfactant and consequences of intrauterine infection. Biol Neonate 1999;76(suppl 1): 2-9.
47. Vigneswaran R: Infection and preterm birth: Evidence of a common causal relationship with bronchopulmonary dysplasia and cerebral palsy. J Paediatr Child Health 2000;36:293-296.
48. Watterberg KL, Demers LM, Scott SM, Murphy S: Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996;97:210-215.
49. Bry K, Lappalainen U, Hallman M: Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. J Clin Invest 1997;99:2992-2999.
50. Hitti J, Krohn MA, Patton DL, Tarcy-Hornoch P, Hillier SL, Cassen EM, Eschenbach DA: Amniotic fluid tumor necrosis factor-α and the risk of respiratory distress syndrome among preterm infants. Am J Obstet Gynecol 1997;177:50-56.
51. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI: Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997;177:825-830.
52. Ghezzi F, Gomez R, Romero R, Yoon BH, Edwin SS, David C, Janisse J, Mazor M: Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia. Eur J Obstet Gynecol Reprod Biol 1998;78:5-10.
53. Yoon BH, Romero R, Kim KS, Park JS, Ki SH, Kim BI, Jun JK: A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999;181: 773-779.
54. Schmidt B, Cao L, Mackensen-Haen S, Kendziorra H, Klingel K, Speer CP: Chorioamnionitis and inflammation of the fetal lung. Am J Obstet Gynecol, in press.
55. Jobe AH: Intrauterine cytokine activation and the role of infection. Biol Neonate 2000;78:244-246.
56. Groneck P, Götze-Speer B, Speer CP: Inflammatory bronchopulmonary response of preterm infants with microbial colonisation of the airways at birth. Arch Dis Child Fetal Neonatal Ed 1996;74:F51-F55.
57. Cordero L, Ayers LW, Davis K: Neonatal airway colonization with gram-negative bacilli: Association with severity of bronchopulmonary dysplasia. Pediatr Infect Dis J 1997;16:18-23.
58. Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G: Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995;126:605-610.
59. Gonzales A, Sosenko IRS, Chan dar J, Hummler H, Claure N, Bancalari E: Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 1996;128:470-478.
60. Wang EEL, Matlow AG, Ohlsson A, Nelson SC: Ureaplasma urealyticum infections in the perinatal period. Clin Perinatol 1997;24:91-105.
61. Buck C, Gallati H, Pohlandt F, Bartmann P: Increased levels of tumor necrosis factor alpha (TNF-alpha) and interleukin 1 beta (IL-1 beta) in tracheal aspirates of newborns with pneumonia. Infection 1994;22:238-241.
62. Grigg J, Barber A, Silverman M: Increased levels of bronchoalveolar fluid interleukin-6 in preterm ventilated infants after prolonged rupture of membranes. Am Rev Respir Dis 1992;145:782-786.
63. Willmot RW, Kassab JT, Kilian PL, Benjamin WR, Douglas SD, Wood RE: Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am Rev Respir Dis 1990;142:365-368.
64. LoMonaco MB, Barber CM, Sinkin RA: Differential cytokine mRNA expression by neonatal pulmonary cells. Pediatr Res 1996;39:248-251.
65. Kwong KYC, Jones CA, Cayabyab R, Lecart C, Khuu N, Rhandhawa I, Hanley JM, Ramanathan R, de Lemos RA, Minoo P: The effects of IL-10 on pro inflammatory cytokine expression (IL-1β and IL-8) in hyaline membrane disease (HMD). Clin Immunol Immunopathol 1998;88:105-113.
66. 1-proteinase inhibitor, and fibronectin in bronchoalveolar lavage fluid from neonates. J Pediatr 1988;113: 732-737.
67. Kotecha S, Wangoo A, Silverman M, Shaw RJ: Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. J Pediatr 1996;128:464-469.
68. Speer CP, Ninjo O, Gahr M: Elastase-alpha-1-proteinase inhibitor in early diagnosis of neonatal septicemia. J Pediatr 1986;108:987-990.
69. Sveger KT, Svenningsen N: Protease inhibitors in bronchoalveolar lavage fluid from neonates with special references to secretory leukocyte protease inhibitor. Acta Paediatr 1992;81:757-759.
70. Yoder MC, Chua R, Tepper R: Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia. Am Rev Respir Dis 1991;143:1044-1048.
71. Merritt TA, Stuard ID, Puccia J, Edwards DK, Finkelstein J, Shapiro DL: Newborn tracheal aspirate cytology: Classification during respiratory distress syndrome and bronchopulmonary dysplasia. J Pediatr 1986;98:949-956.
72. Speer CP, Ruess D, Harms K, Herting E, Gefeller O: Neutrophil elastase and acute pulmonary damage in neonates with severe respiratory distress syndrome. Pediatrics 1993;91:794-799.
73. Gerber CE, Bruchelt G, Stegmann, Schweinsberg F, Speer CP: Presence of bleomycin-detectable free iron in the alveolar system of preterm infants. Biochem Biophys Res Commun 1999;257:218-222.
74. Speer CP, Pabst M, Hedegaard HB, Rest RF, Johnston RB: Enhanced release of oxygen metabolites by monocyte-derived macrophages exposed to proteolytic enzymes: Activity of neutrophil elastase and cathepsin G. J Immunol 1984;133:2151-2156.
75. Schock BC, Sweet DG, Ennis M, Warner JA, Young IS, Halliday HL: Oxidative stress and increased type-IV collagenase levels in bronchoalveolar lavage fluid from newborn babies. Pediatr Res, in press.
76. Bruce MC, Wedig KE, Jentoft N, Martin RJ, Cheng PW, Boat TF, Fanaroff AA: Altered urinary excretion of elastin cross-links in premature infants who develop bronchopulmonary dysplasia. Am Rev Respir Dis 1985;131:568-572.
77. Margraf LR, Tomashefiski JF Jr, Bruse MC, Dahms B: Morphometric analysis of the lung in bronchopulmonary dysplasia. Am Rev Respir Dis 1991;143:391-400.
78. Alnahhas MH, Karathanasis P, Kriss VM, Pauly TH, Bruce MC: Elevated laminin concentrations in lung secretions of preterm infants supported by mechanical ventilation are correlated with radiographic abnormalities. J Pediatr 1997;131:555-560.
79. Juul SE, Kinsella MG, Jackson JC, Truog WE, Standaert TA, Hodson WA: Changes in hyaluronan deposition during early respiratory distress syndrome in premature monkeys. Pediatr Res 1994; 35:238-243.
80. Murch SH, MacDonald TT, Walker-Smith JA, Levin M, Lionetti P, Klein NJ: Disruption of sulphated glycosaminoglycans in intestinal inflammation. Lancet 1993;341:711-714.
81. Jefferies AL, Coates G, O'Brodovich H: Pulmonary epithelial permeability in hyaline-membrane disease. N Engl J Med 1984;311:1075-1080.
82. Davidson D, Drafta D, Wilkens BA: Elevated urinary leukotriene E4 in chronic lung disease of extreme prematurity. Am J Respir Crit Care Med 1995;151:841-845.
83. Gaylord MS, Smith ZL, Lorch V, Blank ML, Snyder H: Altered platelet-activating factor levels and acetylhydrolase activities are associated with increasing severity of bronchopulmonary dysplasia. Am J Med Sci 1996;312:149-154.
84. Kojima T, Hattori K, Hirata Y, Aoki T, SasaiTakedatsu M, Kino M, Kobyashi Y: Endothelin-1 has a priming effect on production of superoxide anion by alveolar macrophages: Its possible correlation with bronchopulmonary dysplasia. Pediatr Res 1996;39:112-116.
85. Mirro R, Armstead W, Leffler C: Increased airway leukotriene levels in infants with severe bronchopulmonary dysplasia. Am J Dis Child 1990;144: 160-161.
86. Niu JO, Munshi UK, Siddiq MM, Parton LA: Early increase in endothelin-1 in tracheal aspirates of preterm infants: Correlation with bronchopulmonary dysplasia. J Pediatr 1998;132:965-970.
87. Speer CP, Ambruso DR, Grimsley JA, Johnston RB: Oxidative metabolism in cord blood monocytes and monocyte-derived macrophages. Infect Immun 1985;50:919-921.
88. Saugstad OD: Bronchopulmonary dysplasia and oxidative stress: Are we closer to an understanding of the pathogenesis of BPD? Acta Paediatr 1997; 86:1277-1282.
89. Coalson J, Winter V, Siler-Khodr T, Yoder B: Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999;160: 1333-1346.